Establishing an Evidence-Based System for Cosmetic Safety and Efficacy Evaluation

The document outlines the development of an evidence-based system for evaluating the safety and efficacy of cosmetics, with a focus on the Chinese market and comparisons to Europe and the U.S. It emphasizes the importance of evaluating cosmetics through various methods, including ingredient analysis, toxicological testing, and clinical trials for safety, and understanding mechanisms and designing rigorous experiments for efficacy. The system aims to protect consumer health, enhance industry credibility, and adapt to scientific advancements. AI technologies are highlighted as transformative tools for enhancing safety and efficacy assessments, predicting risks, and providing personalized skincare recommendations. The document also discusses challenges such as data quality and evolving regulatory guidelines, suggesting that future AI advancements could further revolutionize cosmetic evaluation.